Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention

被引:17
|
作者
Zhou, You [1 ]
Chen, Zhangwei [1 ]
Ma, Jiaqi [1 ]
Chen, Ao [1 ]
Lu, Danbo [1 ]
Wu, Yuan [1 ]
Ren, Daoyuan [1 ]
Zhang, Chi [1 ]
Dai, Chunfeng [1 ]
Zhang, Yaqi [1 ]
Qian, Juying [1 ]
Ge, Junbo [1 ]
机构
[1] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Dept Cardiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Periprocedural myocardial injury; Percutaneous coronary intervention; Cardiac troponin T; CREATINE KINASE-MB; CARDIAC TROPONIN-T; PROGNOSTIC VALUE; MICROEMBOLIZATION; INFARCTION; MYONECROSIS; ELEVATION; DIAGNOSIS; IMPACT; DAMAGE;
D O I
10.1016/j.jjcc.2020.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although technological and equipment innovations have given rise to delicate and safe coronary intervention procedures, periprocedural myocardial injury (PMI) is still one of the common complications. The relationship between PMI, defined by various biomarker thresholds, and clinical prognosis remains controversial. We sought to assess the determinants and prognosis of PMI in patients with stable coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI). Methods: Consecutive stable CAD patients with negative preoperative troponin T levels undergoing elective PCI in our hospital were enrolled from July 2017 to December 2017. PMI was defined as troponin T values >99th percentile upper reference limit (URL) within 16-24 h post-PCI. The correlation of cardiovascular events and PMI was assessed after a median follow-up of 18 months. Results: PMI occurred in 45.3% of the 1572 patients included, with 11.2% having troponin T levels elevated more than 5 times the URL after PCI. Independent risk factors for PMI were age >= 65 years, prior PCI, bifurcation lesion, stent number, and multivessel disease. During the follow-up period, patients with PMI had a higher incidence of unplanned revascularization [10.8% vs. 7.2%, adjusted hazard ratio (adHR) 1.40, 95% confidence interval (CI) 1.04-2.06; p = 0.045] and target vessel revascularization (5.8% vs. 2.7%, adHR 1.90, 95% CI 1.06-3.38; p = 0.030) than those without PMI. However, no significant impact of PMI on the risk of death and myocardial infarction was found. Conclusions: PMI defined by troponin T levels >99th percentile URL correlated with an increased risk of cardiovascular events in stable CAD patients undergoing elective PCI. (C) 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [1] Incidence, Mechanism, Predictors, and Clinical Significance of Periprocedural Myocardial Infarction Due to Percutaneous Coronary Intervention
    Park, Duk-Woo
    Kim, Yong-Giun
    Park, Gyung-Min
    Hwang, Ki Won
    Kwon, Chang Hee
    Jang, Jeong Yoon
    Choi, Suk-Won
    Song, Hae-Geun
    Ahn, Jung-Min
    Kim, Won-Jang
    Lee, Jong-Young
    Kang, Soo-Jin
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    CIRCULATION, 2011, 124 (21)
  • [2] Incidence, Mechanism, Predictors, and Clinical Significance of Periprocedural Myocardial Infarction Due to Percutaneous Coronary Intervention
    Park, Duk-Woo
    Kim, Yong-Giun
    Park, Gyung-Min
    Hwang, Ki-Won
    Kwon, Chang-Hee
    Jang, Jeong-Yoon
    Choi, Suk-Won
    Song, Hae-Geun
    Ahn, Jung-Min
    Kim, Won-Jang
    Lee, Jong-Young
    Kang, Soo-Jin
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 28S - 28S
  • [3] FREQUENCY OF PERIPROCEDURAL MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
    Shaikh, Muhammad Mujtaba
    Lashari, Muhammad Nawaz
    Soomro, Khalida
    PAKISTAN HEART JOURNAL, 2013, 46 (02): : 108 - 112
  • [4] Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention
    Zhou, You
    Chen, Zhangwei
    Chen, Ao
    Ma, Jiaqi
    Dai, Chunfeng
    Lu, Danbo
    Wu, Yuan
    Li, Su
    Chen, Jinxiang
    Liu, Muyin
    Li, ChenGuang
    Lu, Hao
    Qian, Juying
    Ge, Junbo
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (08) : 871 - 880
  • [5] The Effect of Intravenous Vitamin C Infusion on Periprocedural Myocardial Injury for Patients Undergoing Elective Percutaneous Coronary Intervention
    Wang, Zhi Jian
    Hu, Wen Kun
    Liu, Yu Yang
    Shi, Dong Mei
    Cheng, Wan Jun
    Guo, Yong He
    Yang, Qing
    Zhao, Ying Xin
    Zhou, Yu Jie
    CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (01) : 96 - 101
  • [6] Relationship Between Preprocedural Lipid Levels and Periprocedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention
    Maadani, Mohsen
    Sarraf, Nima Sari
    Alilou, Sanam
    Aeinfar, Kamran
    Sadeghipour, Parham
    Zahedmehr, Ali
    Fathollahi, Mahmood Sheikh
    Ghadi, Seyyed Isa Hashemi
    Zavarehee, Abbas
    Zolfaghari, Maryam
    Zolfaghari, Reza
    TEXAS HEART INSTITUTE JOURNAL, 2022, 49 (06)
  • [7] A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
    Naser Aslanabadi
    Hamid Reza Shirzadi
    Hossein Asghari-Soufi
    Samaneh Dousti
    Samad Ghaffari
    Bahram Sohrabi
    Simin Ozar Mashayekhi
    Hadi Hamishehkar
    Taher Entezari-Maleki
    European Journal of Clinical Pharmacology, 2015, 71 : 143 - 149
  • [8] A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
    Aslanabadi, Naser
    Shirzadi, Hamid Reza
    Asghari-Soufi, Hossein
    Dousti, Samaneh
    Ghaffari, Samad
    Sohrabi, Bahram
    Mashayekhi, Simin Ozar
    Hamishehkar, Hadi
    Entezari-Maleki, Taher
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (02) : 143 - 149
  • [9] Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions - is there an association?
    Stipinovic, Mario
    Percin, Luka
    Radonic, Vedran
    Jerkic, Helena
    Jurin, Ivana
    Letilovic, Tomislav
    MEDICINE, 2019, 98 (43)
  • [10] Usefulness of Rosuvastatin to Prevent Periprocedural Myocardial Injury in Patients Undergoing Elective Coronary Intervention
    Takano, Hitoshi
    Ohba, Takayoshi
    Yamamoto, Eisei
    Miyachi, Hideki
    Inui, Keisuke
    Kawanaka, Hidekazu
    Kamiya, Masataka
    Kikuchi, Arifumi
    Takahashi, Yasuhiro
    Tanabe, Jun
    Inami, Shigenobu
    Takagi, Gen
    Asai, Kuniya
    Yasutake, Masahiro
    Ibuki, Chikao
    Tanaka, Kunio
    Kusama, Yoshiki
    Seino, Yoshihiko
    Munakata, Kazuo
    Mizuno, Kyoichi
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (12): : 1688 - 1693